Barinthus Biotherapeutics (BRNS)

1.05

0.00 (0.00%)

At close: Mar 28, 2025, 3:49 PM

1.02

-2.96%

Pre-market: Mar 31, 2025, 05:17 AM EDT

Barinthus Biotherapeutics Cash Flow Statement

Table Mode

Year	FY24	FY23	FY22	FY21	FY20	FY19
Net Income	-61.18M	-73.63M	5.32M	-51.11M	-17.93M	-20.82M
Depreciation & Amortization	5.8M	n/a	4.32M	602K	208K	346.86K
Stock-Based Compensation	4.71M	5.05M	9.88M	16.49M	3.63M	n/a
Other Working Capital	n/a	3.88M	-183K	-63K	-32K	924.57K
Other Non-Cash Items	21.78M	14.57M	-24.09M	8.74M	3.64M	-2.55M
Deferred Income Tax	-44K	-3.09M	-4.34M	-119K	-2.49M	n/a
Change in Working Capital	n/a	6.17M	-5.52M	-7.18M	1.92M	2.94M
Operating Cash Flow	-28.94M	-50.92M	-14.43M	-32.58M	-11.03M	-18.76M
Capital Expenditures	-892K	-5.41M	-6.14M	-1.15M	-293K	-128.35K
Acquisitions	n/a	n/a	387.76K	-11.77M	252.89K	2.06M
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	-5.41M	240.00	n/a	-252.89K	n/a
Investing Cash Flow	-892K	-5.41M	-5.75M	-12.91M	-293K	1.93M
Debt Repayment	n/a	n/a	-159K	n/a	41.24M	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	2.16M	-163K	n/a	119.97M	194K	n/a
Financial Cash Flow	2.16M	1.87M	325K	222.74M	41.44M	1.00
Net Cash Flow	-29.69M	-52.3M	-19.67M	170.79M	31.83M	-16.83M
Free Cash Flow	-29.83M	-56.34M	-20.57M	-33.73M	-11.32M	-18.89M